NBIX Competitors & Alternatives

Compare Neurocrine Biosciences Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

NBIX

Main Stock
$169.40
Tradestie Score
23
Market Cap
$13.59B
P/E Ratio
25.1
Revenue Growth
0.4%
Analyst Upside
+22.9%

Top Competitors

43 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
TEVA Teva Pharmaceutical Industries Limited American Depositary Shares
$43.65
$23.01B 100.6 36 Compare
UTHR United Therapeutics Corp
$593.31
$19.82B 22.5 43 Compare
INCY Incyte Genomics Inc
$121.70
$16.93B 62.4 50 Compare
HIMS Hims & Hers Health, Inc.
$19.73
$12.73B - 46 Compare
RDY Dr. Reddy's Laboratories Limited American Depositary Shares
$14.73
$11.82B 41.2 27 Compare
VTRS Viatris Inc. Common Stock
$20.67
$11.76B - 45 Compare
BMRN BioMarin Pharmaceuticals Inc
$56.70
$10.53B - 53 Compare
ELAN Elanco Animal Health Incorporated Common Stock
$26.50
$10.33B - 27 Compare
RGC Regencell Bioscience Holdings Limited Ordinary Shares
$5.13
$7.83B - 55 Compare
ALKS Alkermes Inc. plc
$46.98
$5.06B - 41 Compare

Data updated: Nov 13, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2836)

43 stocks in this industry